Press Releases

Ignyta and EORTC Announce Entrectinib as 1st Investigational Cancer Agent in EORTC SPECTA

in Media, Press Releases

research-2

SAN DIEGO and BRUSSELS–(BUSINESS WIRE)–Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, and the European Organisation for Research and Treatment of Cancer (EORTC) today announced that they will collaborate via EORTC’s Screening Patients for Efficient Clinical Trial Access (SPECTA) biomarker screening initiative to identify patients who harbor a gene rearrangement to NTRK1, NTRK3, ROS1… Read more »

SPECTAcolor viable next generation multinational cancer clinical trial infrastructure

in Media, Press Releases

dresden

Over 500 patients in and availability of high quality biological materials SPECTAcolor’s successful start has demonstrated its viability to facilitate next generation cancer clinical trials. Nike Air Max 2017 Heren blauw Nike Air Max 2016 Heren It has been successfully implemented across 21 clinical centers located in nine countries in Europe, has now recruited over… Read more »

14M Genomics and EORTC and Announce First Results from their Collaboration on Tumour Profiling

in Media, Press Releases, Science

14mg

Cambridge, UK: 16 November 2015. Chaussures Asics Homme tn requin pas cher 14M Genomics (“14MG”) and The European Organisation for Research and Treatment of Cancer (“EORTC”) today announce the delivery of initial genomic mutation analyses conducted on newly diagnosed cancer patients as part of the EORTC Screening Patients for Efficient Clinical Trial Access (SPECTA) programme…. Read more »

Clinical trials and more… Did you know that the first “clinical trial” dates back to 1747?

in Media, Press Releases, Published Articles, Science

Doctor listening to a patient at her practice

This quarterly edition is dedicated to clinical trials and what they are all about. But first let us provide you with a brief update on the project patients’ status of enrollment. Today, the EORTC is proud to announce that 208 patients have been enrolled in the biobank to be entered in biomarker-led clinical trials. Good… Read more »

First patient accrued on 20 September 2013!

in Media, Press Releases, Science

shutterstock_69623308

NEW! First patients with colorectal cancer enrolled in the EORTC SPECTAcolor Biobanking Project A new approach in treating patients with advanced colorectal cancer: Biomarker based personalized medicine advances to benefit cancer patients! A Biobank purely dedicated to colorectal cancer: Where colorectal cancer facts and figures speak for themselves… Colorectal cancer (CRC) – Cancer of the… Read more »